logo
PennyMac Mortgage Investment Trust Declares Second Quarter 2025 Dividend for Its Common Shares

PennyMac Mortgage Investment Trust Declares Second Quarter 2025 Dividend for Its Common Shares

Business Wire4 days ago

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) announced today that its Board of Trustees declared a cash dividend of $0.40 per common share of beneficial interest for the second quarter of 2025. This dividend will be paid on July 25, 2025, to common shareholders of record as of July 11, 2025.
About PennyMac Mortgage Investment Trust
PennyMac Mortgage Investment Trust is a mortgage real estate investment trust (REIT) that invests primarily in residential mortgage loans and mortgage-related assets. PMT is externally managed by PNMAC Capital Management, LLC, a wholly-owned subsidiary of PennyMac Financial Services, Inc. (NYSE: PFSI). Additional information about PennyMac Mortgage Investment Trust is available at pmt.pennymac.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding management's beliefs, estimates, projections and assumptions with respect to, among other things, the Company's financial results, future operations, business plans and investment strategies, as well as industry and market conditions, all of which are subject to change. Words like 'believe,' 'expect,' 'anticipate,' 'promise,' 'plan,' and other expressions or words of similar meanings, as well as future or conditional verbs such as 'will,' 'would,' 'should,' 'could,' or 'may' are generally intended to identify forward-looking statements. Actual results and operations for any future period may vary materially from those projected herein and from past results discussed herein. Factors which could cause actual results to differ materially from historical results or those anticipated include, but are not limited to: changes in interest rates; the Company's ability to comply with various federal, state and local laws and regulations that govern its business; volatility in the Company's industry, the debt or equity markets, the general economy or the real estate finance and real estate markets; events or circumstances which undermine confidence in the financial and housing markets or otherwise have a broad impact on financial and housing markets; changes in real estate values, housing prices and housing sales; changes in macroeconomic, consumer and real estate market conditions; the degree and nature of the Company's competition; the availability of, and level of competition for, attractive risk-adjusted investment opportunities in mortgage loans and mortgage-related assets that satisfy the Company's investment objectives; the inherent difficulty in winning bids to acquire mortgage loans, and the Company's success in doing so; the concentration of credit risks to which the Company is exposed; the Company's dependence on and potential conflicts with its manager, servicer and their affiliates; the Company's ability to mitigate cybersecurity risks, cybersecurity incidents and technology disruptions; the development of artificial intelligence; the availability, terms and deployment of short term and long term capital; the adequacy of the Company's cash reserves and working capital; the Company's ability to maintain the desired relationship between its financing and the interest rates and maturities of its assets; the timing and amount of cash flows, if any, from the Company's investments; the Company's substantial amount of indebtedness; the performance, financial condition and liquidity of borrowers; the Company's exposure to risks of loss and disruptions in operations resulting from severe weather events, man-made or other natural conditions, including climate change and pandemics; the ability of the Company's servicer, which also provides the Company with fulfillment services, to approve and monitor correspondent sellers and underwrite loans to investor standards; incomplete or inaccurate information or documentation provided by customers or counterparties, or adverse changes in the financial condition of the Company's customers and counterparties; the Company's indemnification and repurchase obligations in connection with mortgage loans it purchases, sells or securitizes; the quality and enforceability of the collateral documentation evidencing the Company's ownership and rights in the assets in which it invests; increased rates of delinquency, defaults and forbearances and/or decreased recovery rates on the Company's investments; the performance of mortgage loans underlying mortgage-backed securities in which the Company retains credit risk; the Company's ability to foreclose on its investments in a timely manner or at all; increased prepayments of the mortgages and other loans underlying the Company's mortgage-backed securities or relating to the Company's mortgage servicing rights and other investments; risks associated with the discontinuation of LIBOR; the degree to which the Company's hedging strategies may or may not protect it from interest rate volatility; the effect of the accuracy of or changes in the estimates the Company makes about uncertainties, contingencies and asset and liability valuations when measuring and reporting upon the Company's financial condition and results of operations; the Company's ability to maintain appropriate internal control over financial reporting; the Company's ability to detect misconduct and fraud; developments in the secondary markets for the Company's mortgage loan products; legislative and regulatory changes that impact the mortgage loan industry or housing market; regulatory or other changes that impact government agencies or government-sponsored entities, or such changes that increase the cost of doing business with such agencies or entities; federal and state mortgage regulations and enforcement; changes in government support of homeownership; changes in government or government-sponsored home affordability programs; changes in the Company's investment objectives or investment or operational strategies, including any new lines of business or new products and services that may subject it to additional risks; limitations imposed on the Company's business and its ability to satisfy complex rules for it to qualify as a REIT for U.S. federal income tax purposes and qualify for an exclusion from the Investment Company Act of 1940 and the ability of the Company's subsidiaries to qualify as REITs for U.S. federal income tax purposes; changes in governmental regulations, accounting treatment, tax rates and similar matters; the Company's ability to make distributions to its shareholders in the future; the Company's failure to deal appropriately with issues that may give rise to reputational risk; and the Company's organizational structure and certain requirements in its charter documents. You should not place undue reliance on any forward-looking statement and should consider all of the uncertainties and risks described above, as well as those more fully discussed in reports and other documents filed by the Company with the Securities and Exchange Commission from time to time. The Company undertakes no obligation to publicly update or revise any forward-looking statements or any other information contained herein, and the statements made in this press release are current as of the date of this release only.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ELV截止日期:Rosen Law Firm敦促損失超過10萬美元的Elevance Health, Inc. (NYSE: ELV)股東與法律事務所聯絡以瞭解有關其權利的資訊
ELV截止日期:Rosen Law Firm敦促損失超過10萬美元的Elevance Health, Inc. (NYSE: ELV)股東與法律事務所聯絡以瞭解有關其權利的資訊

Business Wire

time2 hours ago

  • Business Wire

ELV截止日期:Rosen Law Firm敦促損失超過10萬美元的Elevance Health, Inc. (NYSE: ELV)股東與法律事務所聯絡以瞭解有關其權利的資訊

紐約--(BUSINESS WIRE)--(美國商業資訊)-- 全球投資人權益法律事務所Rosen Law Firm提醒投資人,一名股東代表在2024年4月18日至2024年10月16日期間購買Elevance Health, Inc. (NYSE: ELV)普通股的投資人提起了集體訴訟。Elevance將自身描述為「一家為多個市場提供健康保險計畫的醫療保健公司」。 如欲瞭解更多資訊,請遞交 表格 、向Phillip Kim律師 寄送電子郵件 ,或致電866-767-3653聯絡我們。 指控內容:Rosen Law Firm正在調查對Elevance Health, Inc. (NYSE: ELV)在其業務營運方面誤導投資人的指控。 起訴書指稱,被告做出了虛假和/或誤導性陳述及/或未揭露:在醫療補助(Medicaid)重新認定程序接近完成時,被告向投資人表示,其正密切監控與重新認定程序相關的成本趨勢,且Elevance與各州協商的保費費率足以因應繼續參加醫療補助計畫病患的風險和成本狀況。儘管被告承認醫療補助支出在上升,但仍多次向投資人保證,這已充分反映在Elevance的年度指引中。這些陳述存在重大虛假或誤導性。事實上,重新認定導致Elevance醫療補助會員的疾病嚴重程度和醫療服務利用率顯著上升,因為被移出醫療補助計畫的會員平均而言比保留資格的會員更健康。這一變化的程度並未反映在Elevance與各州的費率協商中,也未體現在其2024年的財務指引裡。訴訟稱,當市場瞭解真實詳情後,投資人蒙受了損失。 現在怎麼辦:您可能有資格參與針對Elevance Health, Inc.的集體訴訟。如果有股東希望擔任該集體訴訟的原告代表,則必須在2025年7月11日之前向法院提出申請。原告代表是指代表其他集體訴訟成員主導訴訟的當事人代表。您無需參與此案即有資格獲得追償。如果您選擇不採取任何行動,您也可以保持缺席集體訴訟成員的身分。如欲瞭解更多資訊,請點選 此處 。 所有代理均為勝訴後取酬。股東無需支付任何費用或開支。 關於Rosen Law Firm:與Rosen Law Firm不同,一些就此等事宜發表公告的法律事務所並不會實際提起證券集體訴訟。身為股東權益訴訟領域公認的領導者, Rosen Law Firm 一直致力於協助股東挽回損失、改善公司治理結構,並追究公司高階主管的違法行為責任。自成立以來,Rosen Law Firm已經為股東挽回了超過10億美元的損失。 請在LinkedIn: 、Twitter: 或Facebook: 上關注我們,以瞭解最新情況。 律師廣告。先前案例不保證可獲致類似結果。 免責聲明:本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用,煩請參照原文,原文版本乃唯一具法律效力之版本。

Bank of America Securities Sticks to Its Buy Rating for Shell (SHEL)
Bank of America Securities Sticks to Its Buy Rating for Shell (SHEL)

Business Insider

time3 hours ago

  • Business Insider

Bank of America Securities Sticks to Its Buy Rating for Shell (SHEL)

In a report released on June 27, Christopher Kuplent from Bank of America Securities maintained a Buy rating on Shell (SHEL – Research Report), with a price target of $86.00. The company's shares closed last Friday at $70.98. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Kuplent is a 2-star analyst with an average return of 0.1% and a 62.90% success rate. Kuplent covers the Energy sector, focusing on stocks such as Shell, Shell (UK), and Tenaris. In addition to Bank of America Securities, Shell also received a Buy from Wells Fargo's Roger Read in a report issued on June 25. However, on June 16, Bernstein downgraded Shell (NYSE: SHEL) to a Hold. Based on Shell's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $69.23 billion and a net profit of $4.78 billion. In comparison, last year the company earned a revenue of $72.48 billion and had a net profit of $7.36 billion

Snowflake Gains Momentum in AI and Data Cloud, Says Truist Securities
Snowflake Gains Momentum in AI and Data Cloud, Says Truist Securities

Yahoo

time4 hours ago

  • Yahoo

Snowflake Gains Momentum in AI and Data Cloud, Says Truist Securities

Snowflake Inc. (NYSE:SNOW) ranks among the best fundamental stocks to buy according to hedge funds. On June 18, Truist Securities restated its Buy rating and $235 price target for Snowflake Inc. (NYSE:SNOW) following encouraging results from the firm's mid-year IT spending survey. The survey revealed that Snowflake's data cloud offerings remained prevalent and suggested that growing momentum would continue. Notably, Truist appeared somewhat surprised by the positive survey results around new product adoption. Truist also noted advancements during Snowflake's recent investor session and user conference, highlighting the company's notable advancements in artificial intelligence over the previous two years. As investments in the AI vertical continue to rise, the research firm believes Snowflake Inc. (NYSE:SNOW) is in an ideal spot to take on additional workloads. Snowflake Inc. (NYSE:SNOW) is an American cloud-based data storage company that operates a platform built on Amazon Web Services, Microsoft Azure, and Google Cloud. It also provides Snowflake Cortex with a set of AI capabilities that employ large language models to analyze unstructured data. While we acknowledge the potential of SNOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store